影响慢性乙型肝炎临床结局的病毒因素
本文综述了与慢性乙型肝炎(CHB)长期临床结局相关的传统及新兴病毒因素,指出不同病毒因素反映CHB的不同方面,整合这些因素有助于更准确判断疾病状态并识别需要及时抗病毒治疗的患者。
要点
- 多种病毒因素与CHB长期临床结局相关,反映疾病不同方面。
- 整合病毒因素可更准确判断疾病状态并识别需及时抗病毒治疗者。
- 本文介绍传统与新兴病毒因素及其在临床中的应用价值。
核心结论
- 整合不同病毒因素有助于更准确判断CHB疾病状态并识别需及时抗病毒治疗以预防不良结局的患者。
研究设计与样本
- 本文为综述,介绍与CHB临床结局相关的传统及新兴病毒因素并讨论其临床应用。
主要发现
- CHB临床结局多样,从自发性缓解到肝硬化、肝衰竭和肝细胞癌等严重不良后果。
- CHB异质性临床过程反映复杂的宿主-病毒相互作用,凸显识别高危患者的困难与必要性。
- 随着HBV病毒学进展,已发现多个病毒因素与CHB患者长期临床结局相关。
- 不同病毒因素反映CHB的不同方面。
临床怎么用
- 临床中可整合不同病毒因素以更准确判断CHB疾病状态并识别需及时抗病毒治疗的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic hepatitis B (CHB) exhibits a variety of clinical outcomes, ranging from spontaneous resolution of hepatitis B to severe adverse consequences, including the development of cirrhosis, hepatic failure, and hepatocellular carcinoma. The heterogeneous clinical courses of chronic hepatitis B virus (HBV) infection reflect the complex host-virus interactions, and point to the difficulty and necessity of identifying the patients at risk. With the advance of HBV virology, several viral factors have been found to be associated with the long-term clinical outcomes of CHB patients. Different viral factors probe different aspects of CHB. Integration of these viral factors may help to determine the disease state of patients more accurately, and identify the patients who require timely antiviral therapy to prevent the development of detrimental clinical outcomes. In this article, we will introduce the conventional and emerging viral factors that are associated with clinical outcomes and discuss their utility in a clinical setting.
引用
- Yang HC, Shih YF, Liu CJ, et al. Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B. J Infect Dis. 2017. PMID: 29156050. doi:10.1093/infdis/jix461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。